Drug intelligence / Profile preview

absorbable gelatin sponge + thrombin

Development stage
Unknown
Lead developer
Pfizer
Modality
Recombinant Proteins and Enzymes
Administration
Topical
01

Overview

Absorbable gelatin sponge + thrombin is a **topical hemostatic combination** used to control bleeding during surgery, comprising an absorbable gelatin sponge (typically derived from porcine or bovine gelatin) and exogenous thrombin, most often bovine or recombinant human thrombin[1][3][5][6]. The gelatin sponge acts as a physical scaffold, absorbs blood, and provides a surface for platelet aggregation, facilitating clot formation by direct physical effects[1][2][3]. Thrombin, the key enzyme in hemostasis, catalyzes the conversion of fibrinogen to fibrin, thereby accelerating clot formation at the site of application[5][3]. When used together, the combination provides **dual mechanisms**: the gelatin sponge offers mechanical support for the clot, while thrombin enhances fibrin formation, resulting in rapid and stable hemostasis even in challenging surgical fields[3][5][6]. The product is **biodegradable** and is absorbed within weeks following application, with minimal tissue reaction[1][3]. The primary indications include surgical hemostasis in procedures such as spinal surgery, neurosurgery, general surgery, dental surgery, and ENT interventions[1][3][6]. This formulation is developed and manufactured by multiple companies, including Pfizer and Baxter, and is available in various branded forms[1][5][3].

Brand names
Gelfoam PlusThrombin-JMI with Absorbable Gelatin Sponge
Other names
absorbable gelatin sponge with thrombingelatin-thrombin hemostatic spongegelatin sponge loaded with thrombinthrombin-impregnated gelatin sponge
02

Targets

BB-031 (Von Willebrand factor)F2R (Protease-activated receptor 1)PAR4 (Protease-activated receptor 4)

Beyond the preview

Go deeper on absorbable gelatin sponge + thrombin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on absorbable gelatin sponge + thrombin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call